Constellation Energy Corporation — FY2023 Form 10-K Summary
Reporting period: Fiscal year ended December 31, 2023, compared with FY2022; this is an annual report, not a standalone fourth-quarter filing. The combined filing covers Constellation Energy Corporation and its operating subsidiary, Constellation Energy Generation, LLC.
Business context
Constellation is a competitive energy supplier and owner of a 33,094-MW generation fleet, nearly 90% carbon-free by output. Its nuclear fleet generated approximately 174 TWh in 2023; nuclear capacity factor was 94.4%, versus 94.8% in 2022. The company serves about 2 million customers and reports five regional operating segments.
Financial performance and liquidity
| Metric (USD millions unless stated) | FY2023 | FY2022 |
|---|---|---|
| Operating revenue | $24,918 | $24,440 |
| Operating income | $1,610 | $495 |
| Net income (loss) attributable to common shareholders | $1,623 | $(160) |
| Diluted EPS | $5.01 | $(0.49) |
| Adjusted EBITDA (non-GAAP) | $4,025 | $2,667 |
| Cash from operating activities | $(5,301) | $(2,353) |
Operating margin was approximately 6.5%, up from 2.0%. Revenue rose 2.0%, while purchased power and fuel expense declined to $16,001 million from $17,462 million. Net income improvement reflected stronger realized margins and generation-to-load optimization, favorable nuclear decommissioning trust (NDT) activity, and an investment fair-value gain. Higher labor and contracting costs, lower capacity revenues, nuclear outages, higher interest expense, and the annual nuclear decommissioning obligation update were offsets. Other, net included $803 million of decommissioning-related income and $307 million of realized and unrealized equity-investment gains; these items make reported earnings sensitive to investment values and accounting adjustments.
Operating cash flow was negative in both years, with FY2023 affected by $8,355 million of outflows from working capital and other noncurrent assets and liabilities and $1,491 million of net collateral posted. Investing cash flow was positive $3,031 million, including $7,340 million of net deferred-purchase-price (DPP) collections, and included $2,422 million of capital expenditures and $1,690 million for acquisitions. Financing cash flow was positive $2,196 million. These cash-flow figures are materially affected by receivables financing, collateral, and timing; they should not be read as a simple measure of underlying earnings.
At year-end, reported cash and restricted cash totaled $454 million. Gross debt was approximately $9.3 billion, comprising $7,677 million of long-term debt, including current maturities, and $1,644 million of short-term borrowings. Available credit capacity was approximately $3.2 billion. Management reported compliance with debt covenants and expects liquidity to cover operating and capital needs. A downgrade below investment grade would trigger estimated incremental collateral of about $1.9 billion. The nuclear decommissioning ARO was $13.9 billion, alongside $16.4 billion of NDT assets; trust assets are restricted and are not general-purpose liquidity.
Material changes and significant developments
- Net income improved by $1,783 million year over year, while Adjusted EBITDA increased by $1,358 million.
- On November 1, 2023, Constellation acquired a 44% interest in the South Texas Project nuclear plant for net cash consideration of $1.65 billion. The acquisition added $378 million of goodwill; its 2023 operating contribution was not material.
- The company repurchased 10.6 million shares for approximately $1 billion in 2023 and had an additional $1 billion of repurchase authority at year-end. The 2024 quarterly dividend was increased 25% to $0.3525 per share.
- FY2023 included $218 million of revenue recognized for Illinois ZECs delivered in prior planning years; payment was expected in Q3 2024.
- Long-term debt increased to $7.7 billion from $4.7 billion, following debt issuance that included financing for the STP acquisition. Net interest expense rose to $431 million from $251 million.
Outlook, risks, and contingencies
The filing does not provide a specific earnings or EPS forecast. Management estimates capital expenditures of approximately $2.8 billion in 2024 and $2.3 billion in 2025, including $875 million of growth investment over two years for nuclear uprates and license renewals, wind repowering, and hydrogen projects subject to policy support. Management expects the Inflation Reduction Act nuclear production tax credit, available beginning in 2024 through 2032, to support eligible nuclear generation; the credit can be up to $15/MWh, subject to program terms and phase-out.
Management’s strategy emphasizes reliable operations, maintaining investment-grade credit ratings, disciplined growth, shareholder returns, and expanded carbon-free generation. Long-term goals include 95% carbon-free owned generation by 2030 and 100% by 2040, subject to policy support and technology development. These goals and growth plans depend on market conditions, regulation, and execution.
- Market and financial risks: Power and fuel price volatility, hedging and collateral needs, customer credit, competition, interest rates, and access to capital. Falling NDT investment values could increase decommissioning funding needs.
- Nuclear and regulatory risks: Plant availability, outage duration, license renewals, environmental requirements, and long-term spent-fuel disposal. Peach Bottom’s subsequent license renewal dates remained subject to NRC review; Conowingo’s 50-year license was vacated and further proceedings continued.
- Fuel supply: Nuclear fuel supply may be affected by Russia-related sanctions or disruption. The company reported no delivery issues to date and said it was increasing inventory and supplier coverage.
- Litigation and environmental matters: The company faces extensive litigation related to the February 2021 Texas winter storm. It recorded no loss contingency for these claims and could not estimate a range of loss; an adverse outcome could be material. Environmental remediation liabilities accrued were $149 million at year-end.
- Other unusual items: FY2023 included $101 million of separation costs. The company also reported $71 million of asset impairments and significant NDT and equity-investment gains in earnings.
Key facts for investors to verify
- How much of FY2023’s earnings and Adjusted EBITDA improvement reflects durable operating margins versus NDT returns, investment gains, hedging mark-to-market, and other non-recurring or volatile items.
- The sources and sustainability of operating cash flow, including the effects of receivables sales, DPP collections, working capital, and collateral movements.
- Progress on STP acquisition integration and the resolution of related proceedings, including the right-of-first-refusal dispute and NRC license-transfer matters.
- Future nuclear tax-credit benefits and state support, alongside license-renewal outcomes and the economics of planned capital expenditures.
- Potential liquidity impact from collateral requirements, debt maturities, and any credit-rating deterioration; also review the scale and funding assumptions of the $13.9 billion nuclear decommissioning obligation.
- Developments in Texas winter-storm litigation, environmental remediation, and other legal or regulatory contingencies for which loss estimates may be uncertain.